Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Squamous Non-Small Cell Lung Cancer (NSCLC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05263947
What this trial is testing

Bevacizumab Combined With Double Doses of Icotinib in Advanced NSCLC Patients With EGFR L858R Mutation

Who this might be right for
Carcinoma, Non-Small-Cell LungBevacizumabTyrosine Kinase Inhibitor+1 more
Tianjin Medical University Cancer Institute and Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT01646125
What this trial is testing

An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations

Who this might be right for
Advanced Non Small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Looking for participantsNCT07416474
What this trial is testing

RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
RemeGen Co., Ltd. 574
Large-scale testing (Phase 3)Study completedNCT00883779
What this trial is testing

Tarceva (Erlotinib) or Placebo in Combination With Platinum-Based Therapy as First Line Treatment in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 451
Early research (Phase 1)Study completedNCT03894618
What this trial is testing

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckMelanomaNon Small Cell Lung Cancer+10 more
Shattuck Labs, Inc. 49
Testing effectiveness (Phase 2)Study completedNCT00036920
What this trial is testing

TLK286 in Treating Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00251524
What this trial is testing

A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Veeda Oncology 69
Testing effectiveness (Phase 2)Looking for participantsNCT07223424
What this trial is testing

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Who this might be right for
Renal Cell CarcinomaNon Small Cell Lung CancerMelanoma+9 more
Diwakar Davar 880
Testing effectiveness (Phase 2)Study completedNCT01829113
What this trial is testing

Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer

Who this might be right for
Non Squamous Non Small Cell Lung Cancer
SCRI Development Innovations, LLC 155
Early research (Phase 1)Ended earlyNCT02365662
What this trial is testing

A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor Receptor

Who this might be right for
Head and Neck Squamous Cell CarcinomaNon-small Cell Lung CancerTriple Negative Breast Cancer+2 more
AbbVie 46
Testing effectiveness (Phase 2)Ended earlyNCT03709706
What this trial is testing

Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With Pembrolizumab

Who this might be right for
Neoplasms
GlaxoSmithKline 34
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Large-scale testing (Phase 3)Study completedNCT03629925
What this trial is testing

Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLC

Who this might be right for
Squamous NSCLC
Innovent Biologics (Suzhou) Co. Ltd. 357
Testing effectiveness (Phase 2)Looking for participantsNCT06943521
What this trial is testing

MT-4561 in Patients With Various Advanced Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Non-small Cell Lung Cancer (NSCLC)Esophageal Cancer+13 more
Tanabe Pharma America, Inc. 27
Not applicableStudy completedNCT04552535
What this trial is testing

A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung

Who this might be right for
Squamous Non-small Cell Lung Cancer
Boehringer Ingelheim 200
Large-scale testing (Phase 3)Study completedNCT00003387
What this trial is testing

Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 366
Post-approval studies (Phase 4)Not Yet RecruitingNCT06483009
What this trial is testing

Efficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Shanghai Chest Hospital 20
Early research (Phase 1)Looking for participantsNCT06561685
What this trial is testing

LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid TumorAdvanced Solid TumorNon-small Cell Lung Cancer+1 more
Eli Lilly and Company 340
Testing effectiveness (Phase 2)Ended earlyNCT05180474
What this trial is testing

GEN1047 for Solid Tumors - First in Human (FIH) Trial

Who this might be right for
Breast Cancer, Breast NeoplasmsEndometrial Cancer, Endometrial NeoplasmOvarian Cancer, Ovarian Neoplasms+1 more
Genmab 179
Large-scale testing (Phase 3)Not Yet RecruitingNCT06335355
What this trial is testing

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd 401
Next Page